Key result
GLP-1 receptor agonists have an uncertain safety profile in the perioperative setting, with current evidence yielding more questions than definitive answers for clinical management.
Why the study?
What are the safety concerns of using GLP-1 receptor agonists in a perioperative setting?
What are the safety concerns of using GLP-1 receptor agonists in a perioperative setting?
The safety of GLP-1 receptor agonists in the perioperative setting remains unclear and requires further investigation.
Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are among the latest class of drugs to be approved for the management of type 2 diabetes mellitus (T2DM). Their use has rapidly increased as...
No takes yet. Share an insight, caveat, or question.
Aquilina et al. (2026) studied this question. GLP-1 receptor agonists have an uncertain safety profile in the perioperative setting, with current evidence yielding more questions than definitive answers for clinical management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: